Yang Z, Conrad T, Zhou Z, Chen J, Dutow P, Klos A
Infect Immun. 2014; 82(8):3154-63.
PMID: 24842924
PMC: 4136226.
DOI: 10.1128/IAI.01833-14.
Armitage C, OMeara C, Harvie M, Timms P, Blumberg R, Beagley K
Immunol Cell Biol. 2014; 92(5):417-26.
PMID: 24445600
PMC: 4088937.
DOI: 10.1038/icb.2013.110.
Johnson R, Kerr M, Slaven J
PLoS One. 2013; 8(5):e63340.
PMID: 23691028
PMC: 3653963.
DOI: 10.1371/journal.pone.0063340.
Bode J, Dutow P, Sommer K, Janik K, Glage S, Tummler B
PLoS One. 2012; 7(11):e50327.
PMID: 23189195
PMC: 3506576.
DOI: 10.1371/journal.pone.0050327.
Yang X, Brunham R
Can J Infect Dis. 2012; 9(2):99-108.
PMID: 22451777
PMC: 3307538.
DOI: 10.1155/1998/395297.
Native properdin binds to Chlamydia pneumoniae and promotes complement activation.
Cortes C, Ferreira V, Pangburn M
Infect Immun. 2010; 79(2):724-31.
PMID: 21134964
PMC: 3028849.
DOI: 10.1128/IAI.00980-10.
Maternal immunity partially protects newborn mice against a Chlamydia trachomatis intranasal challenge.
Pal S, Tatarenkova O, de la Maza L
J Reprod Immunol. 2010; 86(2):151-7.
PMID: 20554327
PMC: 2949516.
DOI: 10.1016/j.jri.2010.04.003.
Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
Pal S, Bravo J, Peterson E, de la Maza L
Infect Immun. 2008; 76(12):5581-7.
PMID: 18809664
PMC: 2583570.
DOI: 10.1128/IAI.00574-08.
Immune Protection Against Chlamydia trachomatis in Females.
Morrison R
Infect Dis Obstet Gynecol. 1996; 4(3):163-70.
PMID: 18476089
PMC: 2364487.
DOI: 10.1155/S106474499600035X.
Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge.
Pal S, Davis H, Peterson E, de la Maza L
Infect Immun. 2002; 70(9):4812-7.
PMID: 12183524
PMC: 128273.
DOI: 10.1128/IAI.70.9.4812-4817.2002.
Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis.
Williams D, Grubbs B, Pack E, Kelly K, Rank R
Infect Immun. 1997; 65(7):2876-82.
PMID: 9199462
PMC: 175404.
DOI: 10.1128/iai.65.7.2876-2882.1997.
Role of CD8 T cells in primary Chlamydia infection.
Magee D, Williams D, Smith J, Bleicker C, Grubbs B, Schachter J
Infect Immun. 1995; 63(2):516-21.
PMID: 7822016
PMC: 173025.
DOI: 10.1128/iai.63.2.516-521.1995.
Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.
Cotter T, Meng Q, Shen Z, Zhang Y, Su H, Caldwell H
Infect Immun. 1995; 63(12):4704-14.
PMID: 7591126
PMC: 173675.
DOI: 10.1128/iai.63.12.4704-4714.1995.
Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.
Morrison R, Feilzer K, Tumas D
Infect Immun. 1995; 63(12):4661-8.
PMID: 7591120
PMC: 173669.
DOI: 10.1128/iai.63.12.4661-4668.1995.
Chronic chlamydial genital infection in congenitally athymic nude mice.
Rank R, Soderberg L, Barron A
Infect Immun. 1985; 48(3):847-9.
PMID: 3997251
PMC: 261285.
DOI: 10.1128/iai.48.3.847-849.1985.
Primary murine Chlamydia trachomatis pneumonia in B-cell-deficient mice.
Williams D, Grubbs B, Schachter J
Infect Immun. 1987; 55(10):2387-90.
PMID: 3498690
PMC: 260718.
DOI: 10.1128/iai.55.10.2387-2390.1987.
Cytotoxic and immunoregulatory function of intestinal lymphocytes in Chlamydia trachomatis proctitis of nonhuman primates.
James S, Graeff A, Zeitz M, Kappus E, Quinn T
Infect Immun. 1987; 55(5):1137-43.
PMID: 2952593
PMC: 260481.
DOI: 10.1128/iai.55.5.1137-1143.1987.
Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera.
Lin J, Yan L, Ho Y, Rice P
Infect Immun. 1992; 60(6):2547-50.
PMID: 1587622
PMC: 257196.
DOI: 10.1128/iai.60.6.2547-2550.1992.